Cue Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Cue Biopharma, Inc. has filed 523 SEC EDGAR filings since 19 Jun 2015

SEC filing history

Showing 76-100 of 523 matching filings.

Per page
25
Current page
4
4

4

Filing date
06 Jun 2025
Reporting date
04 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
06 Jun 2025
Reporting date
04 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38327

DEFA14A

Filing date
27 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90232

SCHEDULE 13G/A filing

Filing date
16 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-38327

ARS

Filing date
25 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38327

DEF 14A

Filing date
25 Apr 2025
Reporting date
03 Jun 2025
Next action
Verify source filing
DEFA14A File 001-38327

DEFA14A

Filing date
25 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-271786

424B5

Filing date
15 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-271786

424B5

Filing date
14 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-38327

PRE 14A

Filing date
14 Apr 2025
Reporting date
14 Apr 2025
Next action
Verify source filing
S-8 File 333-286258

S-8

Filing date
31 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
25 Mar 2025
Reporting date
21 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
25 Mar 2025
Reporting date
21 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .